Cambridge Clinical MS Research

The research of Alasdair Coles, William Brown and Nick Cunniffe

[Cambridge Clinical MS Research @CambridgeMS1]

Finally! The extension studies of the phase 3 alemtuzumab trials, 11–13 years after first prescribing alemtuzumab or interferon-beta The main take-aways are that 30-50% of people needed no futher treatment and no new safety concern emerged
https://t.co/bPhLq68Svl

[Cambridge Clinical MS Research @CambridgeMS1]

@RayDorsey7 @ImperialNHS @ImperialPeople Many congratulations Ray, and thank you for all you have done for MS UK services

[Cambridge Clinical MS Research @CambridgeMS1]

Novel paraneoplastic mechanism for cerebellar ataxia in Erdheim-Chester disease https://t.co/YYVBpReeRc

[Cambridge Clinical MS Research @CambridgeMS1]

Another nice paper on MOG from Tohoku University. 15% of people with #MOGAD have MOG Abs only detectable in the CSF; these are most likely in cases of cortical encephalitis and least in optic neuritis.https://t.co/PMJggAp6pS
@Brain1878
#MOG

[Patrick Malone, MD PhD @patricksmalone]

fascinating, if counterintuitive finding: myelin encapsulating axons actually *increase* the risk of axon degeneration in multiple sclerosis

what implications for remyelination therapies for MS? seems timing of therapy in demyel course might be critical

https://t.co/J9SMBgJWZk

[Multiple Sclerosis News Today @MSNewsToday]

Singapore researchers plan to organize preclinical studies aimed at studying dietary omega-3 and its effects on remyelination. https://t.co/61RdtrWC37

#multiplesclerosis #msnews #msawareness #mscommunity

[Cambridge Clinical MS Research @CambridgeMS1]

Compulsory reading for all clinical trialists in the UK. An accurate description of the problems we face..... Lets hope someone takes notice.
#oshaughnessyreport
#clinicaltrials
@Cambridge_Uni
@nihrbrccam

https://t.co/t0gBz9J4cv

[Cambridge Clinical MS Research @CambridgeMS1]

A big #WorldMSDay today!

[MS Society UK @mssocietyuk]

Today is #WorldMSDay and this year's theme is #MSConnections.

Today, we'll be raising awareness of MS and sharing just some of the ways our community is providing support and helping people affected by MS to connect. 🧡

Join us in raising awareness - RT to spread the word!

[Dimitrios Davalos & Lab @DavalosLab]

Impressive multi-omics and human iNSC modeling work to study senescence in progressive multiple sclerosis by @Pluchinolab at #KSNeuroimmune23 @KeystoneSymp !

[Cambridge Clinical MS Research @CambridgeMS1]

** final reminder ** to register for the Cambridge Centre for Myelin Repair (CCMR)’s 2nd Annual Symposium.
Free to people affected by MS
Register here: https://t.co/O2EJaEhT7a

[Pluchino lab - Regenerative Neuroimmunology @Pluchinolab]

Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis | Science Advances https://t.co/dwl9jy1dFJ

[Cambridge Clinical MS Research @CambridgeMS1]

One week to go! The Annual CCMR symposium for everyone interested in myelin repair: biologists, clinicians and people affected by multiple sclerosis

[Cambridge Centre for Myelin Repair (CCMR) @CentreMyelin]

Would you like to join, but you're not in Cambridge? No problem - register for virtual attendance. 🖥️

[Cambridge Clinical MS Research @CambridgeMS1]

Calling all scientists interested to what it is like to have #MS
What question would you like me to put to our community of people with MS #pwMS in the CCMR symposium?
Reply here or DM
@CentreMyelin
@mssocietyuk
@MStranslate
@MSTrust
@CamNeuro
@Pluchinolab
@Cambridge_Uni

[Cambridge Clinical MS Research @CambridgeMS1]

MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial | Proceedings of the National Academy of Sciences https://t.co/DyqKOAhxmw

[Cambridge Clinical MS Research @CambridgeMS1]

It's here!
Cambridge Centre for Myelin Repair Annual Symposium.
25-26 May 2023
Bruno Stankoff (Paris),
Rosa Chiara Paolicelli (Lausanne)
David Lyons (Edinburgh) with a garden party, food, drinks and music. Book here
https://t.co/O2EJaEhT7a
@CentreMyelin
@CamNeuro

[Cambridge Centre for Myelin Repair (CCMR) @CentreMyelin]

📢Registration now open for our second annual symposium on 25-26 May!
💥A jam-packed lineup of exciting talks from early career researchers, neuroscientists, clinicians and other experts.
✉️We invite people affected by MS to join the conversation on the afternoon of Fri 26 May

[Wellcome @wellcometrust]

How can advanced neuroimaging be used to help understand Parkinson’s disease dementia?

Find out in this latest edition of our ‘Behind the Research’ newsletter ⤵️
https://t.co/NvioCaB0fm

[Cambridge Clinical MS Research @CambridgeMS1]

In vivo MRI is sensitive to remyelination in a nonhuman primate model of multiple sclerosis https://t.co/of3iHj9OCr

[Cambridge Clinical MS Research @CambridgeMS1]

Our annual symposium! Save the date for an in-person or on-line feast of myelin research!

@CentreMyelin @mssocietyuk @NMSS_Aus #myelin #remyelination

[Neurology Journal @GreenJournal]

Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury: https://t.co/GHSNJf237Y

#NeuroTwitter